Sangam (India) Limited

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, PAGEIND.BO has a market cap of 357.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while PAGEIND.BO trades at ₹31,208.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas PAGEIND.BO's P/E ratio is 47.60. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to PAGEIND.BO's ROE of +0.52%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to PAGEIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check PAGEIND.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, PAGEIND.NS has a market cap of 357B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while PAGEIND.NS trades at ₹31,225.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas PAGEIND.NS's P/E ratio is 47.59. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to PAGEIND.NS's ROE of +0.52%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to PAGEIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check PAGEIND.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, KPRMILL.BO has a market cap of 282.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while KPRMILL.BO trades at ₹834.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas KPRMILL.BO's P/E ratio is 33.41. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to KPRMILL.BO's ROE of +0.17%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to KPRMILL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check KPRMILL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, KPRMILL.NS has a market cap of 281.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while KPRMILL.NS trades at ₹834.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas KPRMILL.NS's P/E ratio is 33.31. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to KPRMILL.NS's ROE of +0.17%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to KPRMILL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check KPRMILL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ALOKTEXT.BO has a market cap of 161.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ALOKTEXT.BO trades at ₹37.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ALOKTEXT.BO's P/E ratio is -0.72. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ALOKTEXT.BO's ROE of +0.03%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to ALOKTEXT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ALOKTEXT.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, VTL.NS has a market cap of 154.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while VTL.NS trades at ₹529.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas VTL.NS's P/E ratio is 19.00. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to VTL.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to VTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check VTL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, VTL.BO has a market cap of 153.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while VTL.BO trades at ₹528.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas VTL.BO's P/E ratio is 18.92. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to VTL.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to VTL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check VTL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, WELSPUNIND.NS has a market cap of 153B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while WELSPUNIND.NS trades at ₹159.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas WELSPUNIND.NS's P/E ratio is 29.39. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to WELSPUNIND.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to WELSPUNIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check WELSPUNIND.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, TRIDENT.BO has a market cap of 123.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while TRIDENT.BO trades at ₹23.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas TRIDENT.BO's P/E ratio is 30.33. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to TRIDENT.BO's ROE of +0.09%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to TRIDENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check TRIDENT.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, TRIDENT.NS has a market cap of 123.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while TRIDENT.NS trades at ₹23.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas TRIDENT.NS's P/E ratio is 30.31. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to TRIDENT.NS's ROE of +0.09%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to TRIDENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check TRIDENT.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, WELSPUNLIV.BO has a market cap of 109.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while WELSPUNLIV.BO trades at ₹113.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas WELSPUNLIV.BO's P/E ratio is 46.78. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to WELSPUNLIV.BO's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to WELSPUNLIV.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check WELSPUNLIV.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, WELSPUNLIV.NS has a market cap of 109.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while WELSPUNLIV.NS trades at ₹113.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas WELSPUNLIV.NS's P/E ratio is 46.95. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to WELSPUNLIV.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to WELSPUNLIV.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check WELSPUNLIV.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SWANENERGY.NS has a market cap of 99.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SWANENERGY.NS trades at ₹324.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SWANENERGY.NS's P/E ratio is 13.14. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SWANENERGY.NS's ROE of -0.00%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to SWANENERGY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SWANENERGY.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SWANENERGY.BO has a market cap of 99.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SWANENERGY.BO trades at ₹324.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SWANENERGY.BO's P/E ratio is 12.72. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SWANENERGY.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to SWANENERGY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SWANENERGY.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ARVIND.NS has a market cap of 94.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ARVIND.NS trades at ₹356.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ARVIND.NS's P/E ratio is 23.25. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ARVIND.NS's ROE of +0.11%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ARVIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ARVIND.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ARVIND.BO has a market cap of 94.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ARVIND.BO trades at ₹356.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ARVIND.BO's P/E ratio is 23.24. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ARVIND.BO's ROE of +0.11%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ARVIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ARVIND.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, MANYAVAR.BO has a market cap of 86.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while MANYAVAR.BO trades at ₹360.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas MANYAVAR.BO's P/E ratio is 23.83. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to MANYAVAR.BO's ROE of +0.21%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to MANYAVAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check MANYAVAR.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ABFRL.NS has a market cap of 73B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ABFRL.NS trades at ₹56.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ABFRL.NS's P/E ratio is -8.59. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ABFRL.NS's ROE of -0.11%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ABFRL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ABFRL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ABFRL.BO has a market cap of 72.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ABFRL.BO trades at ₹56.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ABFRL.BO's P/E ratio is -8.58. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ABFRL.BO's ROE of -0.11%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ABFRL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ABFRL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, PGIL.NS has a market cap of 68.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while PGIL.NS trades at ₹1,487.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas PGIL.NS's P/E ratio is 26.15. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to PGIL.NS's ROE of +0.23%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to PGIL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check PGIL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, PGIL.BO has a market cap of 68.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while PGIL.BO trades at ₹1,486.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas PGIL.BO's P/E ratio is 26.14. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to PGIL.BO's ROE of +0.23%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to PGIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check PGIL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ALOKINDS.NS has a market cap of 63.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ALOKINDS.NS trades at ₹12.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ALOKINDS.NS's P/E ratio is -10.19. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ALOKINDS.NS's ROE of +0.03%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to ALOKINDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ALOKINDS.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GARFIBRES.NS has a market cap of 60.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GARFIBRES.NS trades at ₹611.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GARFIBRES.NS's P/E ratio is 28.57. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GARFIBRES.NS's ROE of +0.17%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GARFIBRES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GARFIBRES.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GARFIBRES.BO has a market cap of 60.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GARFIBRES.BO trades at ₹613.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GARFIBRES.BO's P/E ratio is 28.52. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GARFIBRES.BO's ROE of +0.17%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GARFIBRES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GARFIBRES.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RAYMONDLSL.BO has a market cap of 53B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RAYMONDLSL.BO trades at ₹805.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RAYMONDLSL.BO's P/E ratio is 99.79. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RAYMONDLSL.BO's ROE of +0.01%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to RAYMONDLSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RAYMONDLSL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ARVINDFASN.NS has a market cap of 53B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ARVINDFASN.NS trades at ₹404.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ARVINDFASN.NS's P/E ratio is -312.36. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ARVINDFASN.NS's ROE of -0.02%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ARVINDFASN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ARVINDFASN.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ARVINDFASN.BO has a market cap of 53B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ARVINDFASN.BO trades at ₹403.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ARVINDFASN.BO's P/E ratio is -312.13. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ARVINDFASN.BO's ROE of -0.02%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ARVINDFASN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ARVINDFASN.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RAYMONDLSL.NS has a market cap of 52.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RAYMONDLSL.NS trades at ₹805.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RAYMONDLSL.NS's P/E ratio is 99.11. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RAYMONDLSL.NS's ROE of +0.01%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to RAYMONDLSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RAYMONDLSL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GBGLOBAL.NS has a market cap of 46.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GBGLOBAL.NS trades at ₹930.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GBGLOBAL.NS's P/E ratio is -0.03. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GBGLOBAL.NS's ROE of +0.16%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to GBGLOBAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GBGLOBAL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ICIL.NS has a market cap of 46.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ICIL.NS trades at ₹230.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ICIL.NS's P/E ratio is 38.65. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ICIL.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ICIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ICIL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, ICIL.BO has a market cap of 46.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while ICIL.BO trades at ₹230.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas ICIL.BO's P/E ratio is 27.79. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to ICIL.BO's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to ICIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check ICIL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GOKEX.NS has a market cap of 42.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GOKEX.NS trades at ₹576.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GOKEX.NS's P/E ratio is 37.27. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GOKEX.NS's ROE of +0.06%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GOKEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GOKEX.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GOKEX.BO has a market cap of 42.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GOKEX.BO trades at ₹575.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GOKEX.BO's P/E ratio is 37.22. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GOKEX.BO's ROE of +0.06%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GOKEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GOKEX.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, TCNSBRANDS.BO has a market cap of 37B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while TCNSBRANDS.BO trades at ₹584.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas TCNSBRANDS.BO's P/E ratio is -11.87. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to TCNSBRANDS.BO's ROE of -0.63%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to TCNSBRANDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check TCNSBRANDS.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, TCNSBRANDS.NS has a market cap of 36.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while TCNSBRANDS.NS trades at ₹583.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas TCNSBRANDS.NS's P/E ratio is -11.85. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to TCNSBRANDS.NS's ROE of -0.63%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to TCNSBRANDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check TCNSBRANDS.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, KITEX.BO has a market cap of 31.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while KITEX.BO trades at ₹159.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas KITEX.BO's P/E ratio is -18.89. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to KITEX.BO's ROE of +0.04%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to KITEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check KITEX.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, KITEX.NS has a market cap of 31.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while KITEX.NS trades at ₹159.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas KITEX.NS's P/E ratio is -18.89. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to KITEX.NS's ROE of +0.04%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to KITEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check KITEX.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, LUXIND.NS has a market cap of 28.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while LUXIND.NS trades at ₹908.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas LUXIND.NS's P/E ratio is 26.21. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to LUXIND.NS's ROE of +0.06%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to LUXIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check LUXIND.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, LUXIND.BO has a market cap of 28.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while LUXIND.BO trades at ₹908.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas LUXIND.BO's P/E ratio is 26.18. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to LUXIND.BO's ROE of +0.06%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to LUXIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check LUXIND.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, KKCL.NS has a market cap of 26.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while KKCL.NS trades at ₹434.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas KKCL.NS's P/E ratio is 18.86. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to KKCL.NS's ROE of +0.16%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to KKCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check KKCL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, KKCL.BO has a market cap of 26.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while KKCL.BO trades at ₹434.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas KKCL.BO's P/E ratio is 18.84. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to KKCL.BO's ROE of +0.16%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to KKCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check KKCL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RAYMOND.NS has a market cap of 24.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RAYMOND.NS trades at ₹369.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RAYMOND.NS's P/E ratio is 47.27. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RAYMOND.NS's ROE of +1.44%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to RAYMOND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RAYMOND.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RAYMOND.BO has a market cap of 24.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RAYMOND.BO trades at ₹370.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RAYMOND.BO's P/E ratio is 47.37. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RAYMOND.BO's ROE of +1.44%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to RAYMOND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RAYMOND.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, MAYURUNIQ.BO has a market cap of 22.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while MAYURUNIQ.BO trades at ₹500.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas MAYURUNIQ.BO's P/E ratio is 12.76. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to MAYURUNIQ.BO's ROE of +0.18%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to MAYURUNIQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check MAYURUNIQ.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, MAYURUNIQ.NS has a market cap of 22.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while MAYURUNIQ.NS trades at ₹500.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas MAYURUNIQ.NS's P/E ratio is 12.74. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to MAYURUNIQ.NS's ROE of +0.18%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to MAYURUNIQ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check MAYURUNIQ.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GANECOS.BO has a market cap of 21.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GANECOS.BO trades at ₹820.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GANECOS.BO's P/E ratio is 54.02. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GANECOS.BO's ROE of +0.03%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GANECOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GANECOS.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SIYSIL.NS has a market cap of 21.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SIYSIL.NS trades at ₹471.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SIYSIL.NS's P/E ratio is 10.51. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SIYSIL.NS's ROE of +0.16%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SIYSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SIYSIL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SIYSIL.BO has a market cap of 21.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SIYSIL.BO trades at ₹471.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SIYSIL.BO's P/E ratio is 10.50. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SIYSIL.BO's ROE of +0.16%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SIYSIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SIYSIL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GANECOS.NS has a market cap of 21.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GANECOS.NS trades at ₹820.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GANECOS.NS's P/E ratio is 54.00. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GANECOS.NS's ROE of +0.03%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GANECOS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GANECOS.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SANGAMIND.NS has a market cap of 21.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SANGAMIND.NS trades at ₹432.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SANGAMIND.NS's P/E ratio is 36.90. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SANGAMIND.NS's ROE of +0.06%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SANGAMIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SANGAMIND.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, JINDWORLD.BO has a market cap of 21.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while JINDWORLD.BO trades at ₹20.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas JINDWORLD.BO's P/E ratio is 32.45. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to JINDWORLD.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to JINDWORLD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check JINDWORLD.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, JINDWORLD.NS has a market cap of 21.4B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while JINDWORLD.NS trades at ₹20.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas JINDWORLD.NS's P/E ratio is 32.30. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to JINDWORLD.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to JINDWORLD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check JINDWORLD.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, BOMDYEING.NS has a market cap of 21.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while BOMDYEING.NS trades at ₹101.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas BOMDYEING.NS's P/E ratio is 122.81. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to BOMDYEING.NS's ROE of +0.01%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to BOMDYEING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check BOMDYEING.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, BOMDYEING.BO has a market cap of 21.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while BOMDYEING.BO trades at ₹102.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas BOMDYEING.BO's P/E ratio is 21.84. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to BOMDYEING.BO's ROE of +0.01%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to BOMDYEING.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check BOMDYEING.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, NITINSPIN.NS has a market cap of 20.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while NITINSPIN.NS trades at ₹363.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas NITINSPIN.NS's P/E ratio is 12.44. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to NITINSPIN.NS's ROE of +0.13%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to NITINSPIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check NITINSPIN.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, NITINSPIN.BO has a market cap of 20.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while NITINSPIN.BO trades at ₹362.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas NITINSPIN.BO's P/E ratio is 12.39. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to NITINSPIN.BO's ROE of +0.13%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to NITINSPIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check NITINSPIN.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, CANTABIL.BO has a market cap of 19.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while CANTABIL.BO trades at ₹245.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas CANTABIL.BO's P/E ratio is 22.27. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to CANTABIL.BO's ROE of +0.23%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to CANTABIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check CANTABIL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, CANTABIL.NS has a market cap of 19.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while CANTABIL.NS trades at ₹243.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas CANTABIL.NS's P/E ratio is 22.30. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to CANTABIL.NS's ROE of +0.23%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to CANTABIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check CANTABIL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, FILATEX.NS has a market cap of 18.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while FILATEX.NS trades at ₹39.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas FILATEX.NS's P/E ratio is 9.83. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to FILATEX.NS's ROE of +0.14%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to FILATEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check FILATEX.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, FILATEX.BO has a market cap of 18B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while FILATEX.BO trades at ₹39.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas FILATEX.BO's P/E ratio is 9.82. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to FILATEX.BO's ROE of +0.14%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to FILATEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check FILATEX.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SPAL.NS has a market cap of 17.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SPAL.NS trades at ₹706.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SPAL.NS's P/E ratio is 15.96. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SPAL.NS's ROE of +0.13%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SPAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SPAL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SPAL.BO has a market cap of 17.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SPAL.BO trades at ₹701.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SPAL.BO's P/E ratio is 15.93. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SPAL.BO's ROE of +0.13%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SPAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SPAL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SUMEETINDS.NS has a market cap of 15.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SUMEETINDS.NS trades at ₹29.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SUMEETINDS.NS's P/E ratio is 0.62. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SUMEETINDS.NS's ROE of +0.90%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to SUMEETINDS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SUMEETINDS.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SPORTKING.BO has a market cap of 14.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SPORTKING.BO trades at ₹116.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SPORTKING.BO's P/E ratio is 12.63. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SPORTKING.BO's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SPORTKING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SPORTKING.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SPORTKING.NS has a market cap of 14.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SPORTKING.NS trades at ₹117.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SPORTKING.NS's P/E ratio is 12.62. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SPORTKING.NS's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SPORTKING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SPORTKING.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GOCOLORS.NS has a market cap of 14.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GOCOLORS.NS trades at ₹257.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GOCOLORS.NS's P/E ratio is 20.94. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GOCOLORS.NS's ROE of +0.10%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to GOCOLORS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GOCOLORS.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, DOLLAR.NS has a market cap of 14.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while DOLLAR.NS trades at ₹251.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas DOLLAR.NS's P/E ratio is 14.17. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to DOLLAR.NS's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to DOLLAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check DOLLAR.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, DOLLAR.BO has a market cap of 14.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while DOLLAR.BO trades at ₹250.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas DOLLAR.BO's P/E ratio is 14.12. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to DOLLAR.BO's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to DOLLAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check DOLLAR.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RAJRILTD.NS has a market cap of 11.5B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RAJRILTD.NS trades at ₹20.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RAJRILTD.NS's P/E ratio is 49.43. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RAJRILTD.NS's ROE of +0.28%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to RAJRILTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RAJRILTD.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, MONTECARLO.BO has a market cap of 10.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while MONTECARLO.BO trades at ₹505.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas MONTECARLO.BO's P/E ratio is 11.28. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to MONTECARLO.BO's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to MONTECARLO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check MONTECARLO.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, MONTECARLO.NS has a market cap of 10.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while MONTECARLO.NS trades at ₹507.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas MONTECARLO.NS's P/E ratio is 11.27. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to MONTECARLO.NS's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to MONTECARLO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check MONTECARLO.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, AYMSYNTEX.NS has a market cap of 10.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while AYMSYNTEX.NS trades at ₹186.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas AYMSYNTEX.NS's P/E ratio is -704.88. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to AYMSYNTEX.NS's ROE of -0.00%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to AYMSYNTEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check AYMSYNTEX.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, AYMSYNTEX.BO has a market cap of 10.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while AYMSYNTEX.BO trades at ₹185.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas AYMSYNTEX.BO's P/E ratio is -651.96. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to AYMSYNTEX.BO's ROE of -0.00%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to AYMSYNTEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check AYMSYNTEX.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, FAZE3Q.BO has a market cap of 10B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while FAZE3Q.BO trades at ₹421.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas FAZE3Q.BO's P/E ratio is 32.10. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to FAZE3Q.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to FAZE3Q.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check FAZE3Q.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, HIMATSEIDE.NS has a market cap of 10B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while HIMATSEIDE.NS trades at ₹78.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas HIMATSEIDE.NS's P/E ratio is 12.09. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to HIMATSEIDE.NS's ROE of +0.04%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to HIMATSEIDE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check HIMATSEIDE.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, HIMATSEIDE.BO has a market cap of 9.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while HIMATSEIDE.BO trades at ₹78.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas HIMATSEIDE.BO's P/E ratio is 11.65. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to HIMATSEIDE.BO's ROE of +0.04%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to HIMATSEIDE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check HIMATSEIDE.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, FAZE3Q.NS has a market cap of 9.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while FAZE3Q.NS trades at ₹421.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas FAZE3Q.NS's P/E ratio is 31.55. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to FAZE3Q.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to FAZE3Q.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check FAZE3Q.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RUPA.BO has a market cap of 9.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RUPA.BO trades at ₹121.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RUPA.BO's P/E ratio is 14.76. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RUPA.BO's ROE of +0.07%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to RUPA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RUPA.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RUPA.NS has a market cap of 9.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RUPA.NS trades at ₹122.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RUPA.NS's P/E ratio is 14.75. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RUPA.NS's ROE of +0.07%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to RUPA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RUPA.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, CENTENKA.BO has a market cap of 9.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while CENTENKA.BO trades at ₹410.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas CENTENKA.BO's P/E ratio is 15.65. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to CENTENKA.BO's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to CENTENKA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check CENTENKA.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, CENTENKA.NS has a market cap of 9.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while CENTENKA.NS trades at ₹410.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas CENTENKA.NS's P/E ratio is 13.37. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to CENTENKA.NS's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to CENTENKA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check CENTENKA.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, INDORAMA.NS has a market cap of 8.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while INDORAMA.NS trades at ₹31.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas INDORAMA.NS's P/E ratio is 5.97. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to INDORAMA.NS's ROE of +0.37%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to INDORAMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check INDORAMA.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, INDORAMA.BO has a market cap of 8.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while INDORAMA.BO trades at ₹31.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas INDORAMA.BO's P/E ratio is 5.97. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to INDORAMA.BO's ROE of +0.37%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to INDORAMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check INDORAMA.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, NAHARSPING.NS has a market cap of 7.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while NAHARSPING.NS trades at ₹202.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas NAHARSPING.NS's P/E ratio is 38.92. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to NAHARSPING.NS's ROE of +0.01%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to NAHARSPING.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check NAHARSPING.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, NAHARSPING.BO has a market cap of 7.6B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while NAHARSPING.BO trades at ₹203.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas NAHARSPING.BO's P/E ratio is 22.71. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to NAHARSPING.BO's ROE of +0.01%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to NAHARSPING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check NAHARSPING.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, AMBIKCO.NS has a market cap of 7.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while AMBIKCO.NS trades at ₹1,257.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas AMBIKCO.NS's P/E ratio is 11.61. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to AMBIKCO.NS's ROE of +0.07%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to AMBIKCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check AMBIKCO.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, DIGJAMLTD.NS has a market cap of 7.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while DIGJAMLTD.NS trades at ₹82.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas DIGJAMLTD.NS's P/E ratio is 7.77. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to DIGJAMLTD.NS's ROE of +1.91%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to DIGJAMLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check DIGJAMLTD.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, AMBIKCO.BO has a market cap of 7.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while AMBIKCO.BO trades at ₹1,246.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas AMBIKCO.BO's P/E ratio is 11.55. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to AMBIKCO.BO's ROE of +0.07%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to AMBIKCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check AMBIKCO.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GHCLTEXTIL.BO has a market cap of 7.3B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GHCLTEXTIL.BO trades at ₹72.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GHCLTEXTIL.BO's P/E ratio is 12.75. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GHCLTEXTIL.BO's ROE of +0.04%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GHCLTEXTIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GHCLTEXTIL.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, GHCLTEXTIL.NS has a market cap of 7.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while GHCLTEXTIL.NS trades at ₹72.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas GHCLTEXTIL.NS's P/E ratio is 12.70. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to GHCLTEXTIL.NS's ROE of +0.04%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to GHCLTEXTIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check GHCLTEXTIL.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SARLAPOLY.BO has a market cap of 6.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SARLAPOLY.BO trades at ₹81.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SARLAPOLY.BO's P/E ratio is 10.21. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SARLAPOLY.BO's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SARLAPOLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SARLAPOLY.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, SARLAPOLY.NS has a market cap of 6.9B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while SARLAPOLY.NS trades at ₹81.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas SARLAPOLY.NS's P/E ratio is 11.72. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to SARLAPOLY.NS's ROE of +0.12%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to SARLAPOLY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check SARLAPOLY.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RUBYMILLS.NS has a market cap of 6.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RUBYMILLS.NS trades at ₹199.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RUBYMILLS.NS's P/E ratio is 13.87. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RUBYMILLS.NS's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to RUBYMILLS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RUBYMILLS.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RUBYMILLS.BO has a market cap of 6.7B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RUBYMILLS.BO trades at ₹200.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RUBYMILLS.BO's P/E ratio is 12.45. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RUBYMILLS.BO's ROE of +0.08%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to RUBYMILLS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RUBYMILLS.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, UNITEDPOLY.NS has a market cap of 6.4B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while UNITEDPOLY.NS trades at ₹26.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas UNITEDPOLY.NS's P/E ratio is -6.39. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to UNITEDPOLY.NS's ROE of +0.22%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to UNITEDPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check UNITEDPOLY.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RSWM.NS has a market cap of 6.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RSWM.NS trades at ₹134.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RSWM.NS's P/E ratio is 31.74. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RSWM.NS's ROE of +0.02%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to RSWM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RSWM.NS's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, RSWM.BO has a market cap of 6.2B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while RSWM.BO trades at ₹134.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas RSWM.BO's P/E ratio is 77.68. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to RSWM.BO's ROE of +0.02%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to RSWM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check RSWM.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, EASTSILK.BO has a market cap of 6.1B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while EASTSILK.BO trades at ₹76.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas EASTSILK.BO's P/E ratio is 1280.83. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to EASTSILK.BO's ROE of +0.05%. Regarding short-term risk, SANGAMIND.BO is more volatile compared to EASTSILK.BO. This indicates potentially higher risk in terms of short-term price fluctuations for SANGAMIND.BO.Check EASTSILK.BO's competition here

SANGAMIND.BO plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SANGAMIND.BO stands at 21.7B. In comparison, PRECOT.NS has a market cap of 5.8B. Regarding current trading prices, SANGAMIND.BO is priced at ₹438.30, while PRECOT.NS trades at ₹481.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SANGAMIND.BO currently has a P/E ratio of 36.66, whereas PRECOT.NS's P/E ratio is 14.39. In terms of profitability, SANGAMIND.BO's ROE is +0.06%, compared to PRECOT.NS's ROE of +0.06%. Regarding short-term risk, SANGAMIND.BO is less volatile compared to PRECOT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for SANGAMIND.BO.Check PRECOT.NS's competition here